Biotech · Private company · Houston, TX, US
Fannin Partners, LLC
Track this companyFree. Adds Fannin Partners, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Developing Scg3 Raptamers as a novel targeted therapy for wet AMDFiscal year 2025 · $300KNIH RePORTER 1R43EY037173-01A1 · fetched Nov 12, 2026
- Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemiaFiscal year 2025 · $1MNIH RePORTER 5R44CA268530-02 · fetched Nov 12, 2026
- Investigation of a Novel PDE4B Inhibitor for Stimulant Use DisorderFiscal year 2024 · $320KNIH RePORTER 1R43DA060646-01 · fetched Nov 12, 2026